Antoine Yver
2023
In 2023, Antoine Yver earned a total compensation of $1.4M as Chairman of Development at Centessa Pharmaceuticals plc, a 45% decrease compared to previous year.
Compensation breakdown
| Bonus | $221,738 |
|---|---|
| Option Awards | $310,381 |
| Salary | $538,200 |
| Stock Awards | $297,220 |
| Other | $13,200 |
| Total | $1,380,739 |
Yver received $538.2K in salary, accounting for 39% of the total pay in 2023.
Yver also received $221.7K in bonus, $310.4K in option awards, $297.2K in stock awards and $13.2K in other compensation.
Rankings
In 2023, Antoine Yver's compensation ranked 864th out of 3,006 executives tracked by ExecPay. In other words, Yver earned more than 71.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 864 out of 3,006 | 71st |
Division Manufacturing | 507 out of 1,650 | 69th |
Major group Chemicals And Allied Products | 345 out of 918 | 62nd |
Industry group Drugs | 336 out of 881 | 62nd |
Industry Pharmaceutical Preparations | 226 out of 637 | 65th |
Source: SEC filing on May 9, 2024.
Yver's colleagues
We found three more compensation records of executives who worked with Antoine Yver at Centessa Pharmaceuticals plc in 2023.